MetaCap

Concentra Group Holdings Parent Inc. (CON)

NYSE: CONHealth CareMedical SpecialitiesUSD

41.84+0.39 (+0.94%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CON stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
0.60% ($0.25)
Ex-dividend date
Aug 20, 2026
52-week range
19.05 – 44.22
Day range
41.25 – 42.18
Volume / Avg
876.51K / 1.05M
Beta
—

52-week range

$19.05$44.22

CON stock today

On Nov 20, CON ended the session at $41.84, adding $0.39 (0.94%), versus the S&P 500's 3.70% decline. At this level, CON sits near the top of its 52-week range of $19.05 to $44.22: 5.4% below the high, set on Nov 5, 2026 and 119.6% above the low. CON is up 112.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 106.8%.

At 24.8x trailing earnings, Concentra Group Parent trades above the peer-group median of 20.3x. Its forward P/E of 22.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Concentra Group Parent pays an annual dividend of $0.25 per share, a 0.60% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Concentra Group Parent

Company profile

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business.

Industry
Medical Specialities
CEO
Mr. Matthew T. DiCanio M.B.A.
Headquarters
Addison, TX
Employees
9,967
IPO year
2024

Financial highlights

Full financials

In fiscal 2025, Concentra Group Parent generated $2.16 billion in revenue, up 13.9% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $166.4 million (-0.1% year over year), for a net margin of 7.7% versus a median of 9.7% in the prior 3 years. Gross margin was 28.3% (up from 27.8%) and operating margin 15.4%.

Concentra Group Parent annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$2.16B$1.90B$1.84B$1.72B
Growth+13.85%+3.38%+6.60%—
Net income$166.41M$166.54M$179.95M$166.73M
EPS (diluted)$1.30$1.46$1.73$1.60

Analyst forecast

Forecast

Consensus (11 analysts)

strong_buy

Avg. price target

$46.70+11.62%

  • Strong buy 2
  • Buy 9
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $40.00High $51.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.52 vs $0.45
Surprise
+15.56%

Dividends

Dividend history
Annual dividend
$0.25
Last payment
$0.063
Ex-dividend date
Aug 20, 2026

CON news

All CON news

Concentra Group Parent peers

Health Care sector
CON peer companies
CompanyPrice% ChgMarket capCompare
CAICaris Life Sciences Inc.17.58-5.18%$5.04Bvs CON
RDNTRadNet Inc.69.71+0.29%$5.49Bvs CON
GRALGRAIL Inc.99.25-5.33%$4.46Bvs CON
BLLNBillionToOne Inc. Class A89.92-0.31%$4.30Bvs CON
CDNACareDx Inc.70.00-2.67%$3.68Bvs CON
ACHCAcadia Healthcare Company Inc.34.60+0.38%$3.22Bvs CON
OSCROscar Health Inc. Class A24.73-5.50%$7.68Bvs CON
CELCCelcuity Inc.53.35-5.26%$2.61Bvs CON

Indexes, lists and sector

Concentra Group Parent stock FAQ

What is Concentra Group Parent's stock price today?

CON last traded at $41.84 as of Nov 20, 4:00 PM EST, up 0.94% on the day. Prices are delayed at least 15 minutes.

Does Concentra Group Parent pay a dividend?

Yes. Concentra Group Parent pays $0.25 per share annually, a 0.60% yield. The most recent dividend of $0.063 had an ex-dividend date of Aug 20, 2026.

What is CON's P/E ratio?

CON trades at a trailing P/E ratio of 24.76 and a forward P/E of 21.99, compared with a median of 20.3 for its closest peers.

Who is Concentra Group Parent's CEO?

Mr. Matthew T. DiCanio M.B.A. is the chief executive officer of Concentra Group Holdings Parent Inc., which has about 9,967 employees.

What is the CON 52-week high?

The 52-week high for CON is $44.22 and the 52-week low is $19.05. The stock is currently 5.4% below its high.

Compare CON